Vaccines news
|
view more news
12-December-2011
15-July-2011
16-June-2011
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
09-June-2011
19-May-2011
Novartis welcomes endorsement of Pandemic Influenza Preparedness Framework at World Health Assembly
12-May-2011
Novartis vaccine Menveo® now supported by three years of immune persistence and safety data
22-Mar-2011
Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China
31-Jan-2011
27-Jan-2011
Innovation drives Novartis to double-digit growth for 2010
23-Dec-2010
Novartis submits Bexsero®, a multi-component meningococcal B vaccine, for regulatory review in Europe
04-Nov-2010
Features
Experience Novartis on YouTube
See the latest Novartis video online now.
Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment
Cornerstone of Novartis strategy is focus on innovation through most productive R&D program in the industry.
Innovating beyond the Vaccine: VaxTrak puts value in the hands of patients and families
Novartis Vaccines and Diagnostics (NV&D) has developed a way to help parents, families and vaccine consumers track vaccinations using the iPhone®.
Vaccine Industry Excellence Awards
Novartis recognized for top vaccine pipeline at 2011 Vaccine Industry Excellence Awards
FORTUNE
Novartis #1 pharmaceutical company in Fortune's World's Most Admired Companies 2011.
Latest information and updates about Influenza A(H1N1). Including Patient Information Leaflets, SPC and online reporting.
U.S. HEALTHCARE PROVIDERS
For U.S. Healthcare Providers ordering Novartis vaccines just got easier. Now you can:
- manage inventory
- check order status
- track vaccine orders
- learn about online discounts.
Your New online order portal for vaccines is just a click away.